Abbott has warned that 3 million of its continuous glucose monitors may provide incorrect low readings. Here's what to know.

Patients with affected devices should stop using them. They are eligible for free replacements, Abbott said.

Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle ...

FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...

A subset of FreeStyle Libre 3 and Libre 3 Plus sensors can give falsely low glucose readings, with 736 serious adverse events and seven deaths reported worldwide. Only specific Libre 3 and Libre 3 ...

The decision to recall approximately three million sensors follows reports of potentially life-threatening errors in the ...